Cargando…
The effect of a single dose of BNT162b2 vaccine on the incidence of severe COVID-19 infection in patients on chronic hemodialysis: a single-centre study
INTRODUCTION: In this single-centre retrospective observational study, the 8-week safety and the efficiency of a single dose of BNT162b2 vaccine was studied in 83 HD patients. METHODS: All clinically stable adult ESRD patients on chronic HD for at least 4 weeks were screened for participation in the...
Autores principales: | Cserep, Gabor, Morrow, David, Latchford, Karen, Jesset, Rachael, Dosa, Agnes, Kirmizis, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319692/ https://www.ncbi.nlm.nih.gov/pubmed/34324086 http://dx.doi.org/10.1007/s10157-021-02118-4 |
Ejemplares similares
-
Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis
por: Kitamura, Mineaki, et al.
Publicado: (2022) -
Single BNT162b2 vaccine dose produces seroconversion in under 60 s cohort
por: Shachor-Meyouhas, Yael, et al.
Publicado: (2021) -
Humoral responses to BNT162b2 SARS-CoV-2 and hepatitis B vaccines are associated in patients on maintenance hemodialysis: a single-centre experience in Belgium
por: Van Regemorter, Elliott, et al.
Publicado: (2021) -
BNT162b2 vaccine uptake and effectiveness in UK healthcare workers – a single centre cohort study
por: Azamgarhi, Tariq, et al.
Publicado: (2021) -
Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients
por: Attias, Philippe, et al.
Publicado: (2021)